ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML
Product details
Registration number: SIN17026P
Classification: Prescription Only
Active ingredients: Ravulizumab
Strength: 100 mg/mL
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: ASTRAZENECA SINGAPORE PTE LTD
ATC code: L04AJ02
HSA approval date: 19 June 2024
Manufacturer(s):
- Catalent Indiana, LLC
- Alexion Pharma International Operations Limited (AAMF)
Manufacturing country/countries: UNITED STATES; IRELAND
What are the HSA registration number and classification for ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17026P
Classification: Prescription Only
What active ingredients and strength are recorded for ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Ravulizumab
Strength: 100 mg/mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: ASTRAZENECA SINGAPORE PTE LTD
Which manufacturers and countries are listed for ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Catalent Indiana, LLC
- Alexion Pharma International Operations Limited (AAMF)
Manufacturing country/countries: UNITED STATES; IRELAND
Where can I look up ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17026P or the exact product name ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML. The general register link does not preselect this product.
What are the source dates for this ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17026P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)